Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. a twenty-four—week controlled clinical trial

Arthritis & Rheumatism ◽

10.1002/art.1780300401 ◽

1987 ◽

Vol 30 (4) ◽

pp. 361-368 ◽

Author(s):

H. Hamdy ◽

R. J. R. McKendry ◽

E. Mierins ◽

J. A. Liver

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Low Dose ◽

Controlled Clinical Trial ◽

Dose Methotrexate

Download Full-text

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

Arthritis & Rheumatism ◽

10.1002/art.1780280702 ◽

1985 ◽

Vol 28 (7) ◽

pp. 721-730 ◽

Author(s):

H. James Williams ◽

Robert F. Willkens ◽

Cecil O. Samuelson ◽

Graciela S. Alarcón ◽

Maria Guttadauria ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Low Dose ◽

Controlled Clinical Trial ◽

Download Full-text

Efficacy of Leflunomide 100mg Weekly Compared to Low Dose Methotrexate in Patients With Active Rheumatoid Arthritis. Double Blind, Randomized Clinical Trial

Reumatología Clínica (English Edition) ◽

10.1016/j.reumae.2012.07.005 ◽

2012 ◽

Vol 8 (5) ◽

pp. 243-249

Author(s):

Jorge Jaimes-Hernández ◽

Claudia Irene Meléndez-Mercado ◽

Angélica Mendoza-Fuentes ◽

Pablo Aranda-Pereira ◽

Gilberto Castañeda-Hernández

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Randomized Clinical Trial ◽

Active Rheumatoid Arthritis ◽

Low Dose ◽

Double Blind ◽

Dose Methotrexate

Download Full-text

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis – a controlled clinical trial

Classic Papers in Rheumatology ◽

10.3109/9780203214237-213 ◽

2001 ◽

pp. 434-435

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Low Dose ◽

Controlled Clinical Trial ◽

Download Full-text

An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis

Drug Design Development and Therapy ◽

10.2147/dddt.s118298 ◽

2017 ◽

Vol Volume11 ◽

pp. 985-994 ◽

Author(s):

LS Martin-Martin ◽

F Giovannangeli ◽

E Bizzi ◽

U Massafra ◽

E Ballanti ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Disease Activity ◽

Low Dose ◽

Controlled Clinical Trial ◽

Low Disease Activity

Download Full-text

Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial

BMC Musculoskeletal Disorders ◽

10.1186/s12891-017-1673-3 ◽

2017 ◽

Vol 18 (1) ◽

Author(s):

Harindu Wijesinghe ◽

Priyadharshini Galappatthy ◽

Rajiva de Silva ◽

Suranjith L. Seneviratne ◽

Ushagowry Saravanamuttu ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Low Dose ◽

Controlled Clinical Trial ◽

Double Blind ◽

Refractory Rheumatoid Arthritis

Download Full-text

A clinical trial of low dose methotrexate therapy in patients with rheumatoid arthritis

Japanese Journal of Clinical Immunology ◽

10.2177/jsci.28.389 ◽

2005 ◽

Vol 28 (6) ◽

pp. 389-397 ◽

Author(s):

Shouhei NAGAOKA ◽

Mitsuyuki NAKAMURA ◽

Akiko SENUMA ◽

Akiko SEKIGUCHI

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Low Dose ◽

Methotrexate Therapy ◽

Dose Methotrexate

Download Full-text

Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Annals of Internal Medicine ◽

10.7326/0003-4819-136-1-200201010-00006 ◽

2002 ◽

Vol 136 (1) ◽

pp. 1 ◽

Author(s):

Amalia A. van Everdingen ◽

Johannes W.G. Jacobs ◽

Dirk R. Siewertsz van Reesema ◽

Johannes W.J. Bijlsma

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Side Effects ◽

Active Rheumatoid Arthritis ◽

Low Dose ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Disease Modifying ◽

Dose Prednisone

Download Full-text

Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2011-201605 ◽

2012 ◽

Vol 72 (3) ◽

pp. 337-344 ◽

Author(s):

Paul P Tak ◽

Andra Balanescu ◽

Vira Tseluyko ◽

Silvia Bojin ◽

Edit Drescher ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Trial ◽

Chemokine Receptor ◽

Controlled Clinical Trial ◽

Ccr1 Antagonist

Download Full-text

Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patients

Expert Opinion on Drug Safety ◽

10.1080/14740338.2022.2003328 ◽

2021 ◽

Author(s):

Jette A. van Lint ◽

Tom Bakker ◽

Peter M. ten Klooster ◽

Eugene P. van Puijenbroek ◽

Harald E. Vonkeman ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Adverse Drug Reactions ◽

Low Dose ◽

Drug Reactions ◽

Dose Methotrexate

Download Full-text

Fatal pneumocystis carinii pneumonia as a complication of methotrexate in rheumatoid arthritis

Acute Medicine Journal ◽

10.52964/amja.0036 ◽

2003 ◽

Vol 2 (1) ◽

pp. 25-26

Author(s):

M Suleman ◽

◽

MB Chaudri ◽

C Deighton ◽

RB Hubbard ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Female Patient ◽

Pneumocystis Carinii Pneumonia ◽

Low Dose ◽

Opportunistic Infections ◽

Pneumocystis Carinii ◽

Dose Methotrexate ◽

Refractory Rheumatoid Arthritis ◽

Low dose methotrexate has been used successfully to treat patients with refractory rheumatoid arthritis.1 Methotrexate-induced pneumonitis occurs in about 1 to 5% of patients, although opportunistic infections have also been reported.1 We report a case of fatal pneumocystis carinii pneumonia (PCP) in an otherwise healthy female patient treated with methotrexate for rheumatoid arthritis and review the literature.

Download Full-text